Home›Stock Screener›Metropolis Healthcare

Metropolis Healthcare Share Price Today | Stock Price & Metropolis Healthcare Share Screener

METROPOLIS Healthcare Services
Live Share Price NSE
₹564.30
▼ -2.70 (-0.48%)
2026-11-18 00:00:00
Live Share Price BSE
₹563.95
▼ -3.05 (-0.54%)
2026-11-18 00:00:00

As of November 18, 2026, the live Metropolis Healthcare share price (NSE: METROPOLIS) is ₹564.30 on NSE and ₹563.95 on BSE, down 0.48% from the previous close, with shares trading between ₹561.50 and ₹576.80 in today's trading session, and a 52-week range of ₹421.75–₹2,050.50. Track Metropolis Healthcare market cap to gauge the company's total market size. Use the Metropolis Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Metropolis Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹433 and net income of ₹51, with EBITDA of ₹116, an operating margin of 25.0% and a profit margin of 11.8%.

Metropolis Healthcare Market Cap ₹11,758.88 Cr.
METROPOLIS P/E Ratio (TTM) 52.90
Metropolis Healthcare P/B Ratio 7.27
EPS (TTM) ₹9.19
Dividend Yield 0.17%
Debt to Equity 0.15
METROPOLIS 52 Week High ₹2050.50
Metropolis Healthcare 52 Week Low ₹421.75
Operating Margin 25.00%
Profit Margin 11.78%
METROPOLIS Revenue (TTM) ₹433.00
EBITDA ₹116.00
Net Income ₹51.00
Total Assets ₹2,138.00
Total Equity ₹1,525.00

Metropolis Healthcare Share Price Chart

Track the current stock price of Metropolis Healthcare with an interactive chart. Analyse METROPOLIS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Metropolis Healthcare stock quote in one place.

The quote of ₹564.30 sits between the 52-week low of ₹421.75 and the 52-week high of ₹2,050.50, and the latest session moved -0.48% from the previous close.

Metropolis Healthcare Company Profile - Fundamental Screener

Screen Metropolis Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for METROPOLIS shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, with Ameera Sushil Shah listed as chairperson or CEO, and it trades under ISIN INE112L01020.

Business Overview

Metropolis Healthcare Limited is an Indian diagnostic services company operating across India and Africa. Founded in 1980 as a pathology partnership, it has evolved into a public company offering a wide range of clinical laboratory tests and profiles. The company operates through a hub and spoke model with 115 clinical...more

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

Chairperson/CEO Ameera Sushil Shah
ISIN INE112L01020

Metropolis Healthcare Balance Sheet Screener

Screen METROPOLIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹2,138, up from ₹1,867 in 2025.

Latest statistics put total assets at ₹2,138 and shareholder funds at ₹1,525, with a leverage ratio of 0.15.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018

Assets

Total Assets 2,138 1,867 1,555 1,502 1,530 1,004 752 553 530
Current Assets 0 0 0 0 0 0 0 0 0
Fixed Assets 1,601 1,447 1,177 1,121 1,059 343 296 213 207

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0
Current Liabilities 280 238 210 246 341 92 58 8 11
Non-Current Liabilities 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 1,525 1,335 1,099 991 888 708 525 420 429
Share Capital 42 10 10 10 10 10 10 10 10
Reserves & Surplus 1,461 1,313 1,078 978 876 696 513 409 405

Metropolis Healthcare Income Statement Screener - Profit & Revenue Analysis

Screen Metropolis Healthcare income statement and profit fundamentals. Analyze METROPOLIS quarterly results. Metropolis Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹433 and net profit was ₹51, equal to earnings per unit of ₹2.46, at an operating margin of 25%.

In that period expenses were ₹317, interest cost ₹8 and tax ₹19. The next period listed, 2026-Jun, shows revenue of ₹455 and net profit of ₹57.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 433 455 505 352 394 430 415 334 316 353 325 284 280 310 293
Expenses 317 339 363 283 296 321 320 251 235 260 251 212 214 234 226

Operating Costs and Margins

EBITDA 116 116 143 69 97 109 95 83 81 93 75 72 66 76 67
Operating Profit % 25.00% 25.00% 27.00% 18.00% 23.00% 25.00% 21.00% 24.00% 25.00% 26.00% 22.00% 25.00% 23.00% 24.00% 22.00%
Depreciation 39 32 33 29 31 32 32 26 26 27 28 23 21 22 25
Interest 8 6 7 5 5 6 6 6 5 5 5 6 6 6 5

Profit and Earnings

Profit Before Tax 70 78 103 36 61 71 57 51 51 61 42 42 39 48 37
Tax 19 21 27 7 16 18 15 14 13 15 11 8 10 13 10
Net Profit 51 57 76 29 45 53 42 37 38 47 32 34 29 36 27
EPS 2.46 2.73 3.64 5.69 8.70 10.17 7.99 7.11 7.41 9.08 6.12 6.51 5.62 6.92 5.30

Metropolis Healthcare Cash Flow Screener - Liquidity Fundamentals

Screen METROPOLIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹351, and net cash flow was an inflow of ₹15.

Over the same period, investing activities used ₹220 and financing activities used ₹115.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 351 263 264 247 253 249 215 90 104 102
Investing Activities -220 -199 -89 48 -736 63 -104 36 1 -86

Financing and Net Cash

Financing Activities -115 -87 -181 -292 163 -33 -55 -118 -87 -17
Net Cash Flow 15 -23 -6 3 -321 279 56 8 18 -1

Metropolis Healthcare Shareholding Pattern Screener

See Metropolis Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Metropolis Healthcare promoter holding and ownership changes for METROPOLIS on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 48.87%, foreign institutions 10.43%, domestic institutions 35.79% and the public 3.99%, spread across 48,488 shareholders.

The shareholder count was 48,488 in 2026-Mar, compared with 50,636 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 48.87% 48.86% 47.82% 48.90% 48.89% 48.89% 48.88% 49.67%

Institutional Investors

FII Holding 10.43% 11.03% 11.67% 15.29% 12.83% 12.52% 11.69% 18.90%
DII Holding 35.79% 35.12% 35.49% 30.30% 32.40% 33.10% 34.73% 24.86%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 3.99% 4.06% 4.10% 3.84% 4.16% 3.69% 3.87% 5.24%
Other Holding 0.92% 0.93% 0.92% 1.68% 1.72% 1.80% 0.83% 1.33%
Shareholder Count 48,488 50,636 50,592 49,293 50,015 47,846 46,670 68,283

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Metropolis Healthcare. Metropolis Healthcare dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹5.00 per unit for 2026-March, a yield of 0.87%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹5.00, ₹0.00 and ₹4.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹5.00 0.87%
2025-March ₹0.00 0.00%
2024-March ₹4.00 1.02%
2023-March ₹8.00 1.86%
2022-March ₹8.00 2.56%
2021-March ₹8.00 1.57%
2020-March ₹8.00 1.43%
2019-March ₹13.26 4.13%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Metropolis Healthcare Stock Index Membership - Nifty & Sensex

See which indices include Metropolis Healthcare stock. Check METROPOLIS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 16 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY MIDSML 400
NIFTY SMALLCAP250 MOMENTUM QUALITY 100
NIFTY SMALLCAP250 QUALITY 50
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH

Metropolis Healthcare Market Events Screener - Corporate Actions

Get Metropolis Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Metropolis Healthcare stock events that may affect METROPOLIS share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Dividend dated November 9, 2026, with a record date of November 9, 2026.

It is followed by Quarterly Result Announcement dated November 3, 2026 and Annual General Meeting dated August 18, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-09 2026-11-09 Dividend ₹ 1.00 /share 3.00%
2026-11-03 2026-11-03 Quarterly Result Announcement NA 1.77%
2026-08-18 2026-08-18 Annual General Meeting NA -2.75%
2026-08-04 2026-08-04 Quarterly Result Announcement NA 3.29%
2026-05-19 2026-05-19 Dividend ₹ 1.00 /share -7.43%
2026-05-13 2026-05-13 Quarterly Result Announcement NA 8.23%
2026-03-20 2026-03-20 Bonus 3:1 0.35%
2026-02-04 2026-02-04 Quarterly Result Announcement NA 5.61%
2025-11-11 2025-11-11 Dividend ₹ 4.00 /share -3.41%
2025-11-04 2025-11-04 Quarterly Result Announcement NA 2.62%
2025-08-13 2025-08-13 Annual General Meeting NA 7.95%
2025-08-07 2025-08-07 Quarterly Result Announcement NA 1.82%
2025-05-13 2025-05-13 Quarterly Result Announcement NA 1.03%
2025-02-04 2025-02-04 Quarterly Result Announcement NA 2.86%
2024-11-08 2024-11-08 Quarterly Result Announcement NA -0.31%

Metropolis Healthcare Competitors Screener - Peer Stocks Comparison

Screen METROPOLIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 125,272 53.90 25,420 15.58% 2,003 61.89
Max Healthcare Institute 100,339 71.20 8,536 18.82% 1,442 76.17
Manipal Health Enterprises 92,333 104.20 10,521 25.80% 917 60.80
Aster DM Quality Care 64,325 116.10 4,769 11.25% 427 57.55
Fortis Healthcare 60,910 57.00 9,179 16.93% 1,064 57.30
Narayana Hrudayalaya 38,984 45.00 7,996 43.43% 811 61.49
Global Health 38,830 62.80 4,509 19.56% 554 64.64
Dr. Lal Path Labs 33,237 57.20 2,864 12.11% 510 54.28
Krishna Institute of Medical Sciences 32,269 163.00 3,931 28.16% 242 66.73
Syngene International 17,533 95.70 3,809 2.56% 317 61.78

Metropolis Healthcare Company Announcements - News & Reports Screener

Screen METROPOLIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 12, 2026.

The next most recent announcements are dated November 5, 2026 and November 4, 2026.

Date Update Actions
2026-11-12 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-11-05 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-04 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-03 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-11-03 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-03 Corporate Action-Board approves Dividend -
2026-11-03 Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2026 -
2026-11-03 Board Meeting Outcome for The Meeting Held Today (November 03 2026) -
2026-11-03 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-11-03 Grant Of Stock Benefits -
2026-10-28 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-28 Board Meeting Intimation for Board Meeting Intimation For Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2026 And Declaration Of Interim Dividend If Any For The Finan -
2026-10-14 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-10-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-05 Business Update For Q2FY27 -
2026-09-28 Closure of Trading Window -
2026-09-09 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-09-07 Announcement under Regulation 30 (LODR)-Restructuring -
2026-09-07 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹564.30, within a 52-week range of ₹421.75 to ₹2,050.50. The P/E ratio is 52.90 and the P/B ratio is 7.27, with earnings per unit of ₹9.19. Market capitalisation stands at ₹11,758.88 Cr and the dividend yield is 0.17%. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 9 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.